-
T Cell Help Is Critical in Determining Mode of Alloantibody-Mediated Allograft Rejection
-
T Cell Senescence and Accelerated Immunologic Aging in Children Awaiting Kidney Transplantation
-
T-Cell Depletion by Anti-CD3ε Is Associated with Dyshomeostasis in the Immature B-Cell Pool
-
T-Cell Mediated Rejections Do Not Induce De Novo Donor Specific Antibodies in Non-Sensitized Kidney Transplant Recipients: A Longitudinal Cohort Analysis
-
Tacrolimus Concentration Variability Is Associated with Delayed Graft Function and Diminished Renal Function in Kidney Transplant Recipients
-
Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
-
Tacrolimus Granules Use in Kidney Transplanted Infants. Dose and Safety
-
Tacrolimus Is More Than Just a Calcineurin Inhibitor: It Suppresses NF-κB Activation in Human T Cells
-
Tacrolimus Metabolism Rate Influences the Kidney Function after Liver Transplantation, The
-
Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection after Renal Transplantation: A Pooled Analysis from Three Randomised-Controlled Clinical Trials
-
Tacrolimus-Induced Diabetes Compared to Cyclosporine May Lead to More Diabetic Complications Post Heart Transplant
-
Targeting Inositol-Requiring Enzyme 1α in Prevention of Donor Specific Antibody (DSA) Mediated Rejection
-
Targeting of mTORC2 in DC Elicits an Enhanced Pro-Inflammatory Profile and Th17 Alloresponse
-
Tauroursodeoxycholic Acid Alleviate Ischemia-Reperfusion Injury in Donation after Cardiac Death Liver Transplantation
-
TBX21 Polymorphism Influence BK Virus Viremia in Solid Organ Transplant Recipients (SOT)
-
TCMR Is Underdiagnosed in BK Virus Nephropathy: A Tale of 2 Populations
-
TCR-Directed Immune Therapy Restores Self Tolerance and Significantly Prolongs Islet Allograft Survival in Diabetic NOD Mice
-
Technical Variant Liver Transplantation or Whole Liver Transplantation for Pediatric Patients? A Meta-Analysis
-
Telaprevir Based Combination Therapy for the Treatment of Recurrent HCV in Liver Transplant Recipients: Promising Early Results, Late Disappointment
-
Telomere Length of Living Kidney Donors and Recipients and Chronic Graft Dysfunction in Kidney Transplants
-
Ten-Year Experience in Pediatric Renal Transplant Using Thymoglobulin Induction and Steroid Minimization
-
Tetrahydrobiopterin Prevents Brain Death Exacerbated Ischemia Reperfusion Injury in Pancreatic Isografts
-
Th17 Memory Cells Are More Dependent on Coinhibition by CTLA-4 Than Th1 Memory Cells and Are Associated with Rejection in Patients Treated with Belatacept
-
Theaflavin (TF) Ameliorates Kidney Ischemia-Reperfusion Injury in Mice
-
Therapeutic Dosing of Mycophenolate Mofetil (MMF) in Renal Allograft Recipients Decreases with Increasing Age
-
Therapeutic Management and Outcome of the Novo Prostate Cancer in Renal Transplant Recipients
-
Therapeutic Mycophenolic Acid Area-Under-Curve (MPA AUC) Levels Abolish Donor-Specific Antibody Formation in Established and De Novo Renal Transplant Patients
-
Therapy with mTOR Inhibitors in Polyomavirus Nephropathy: A Five Year Follow Up
-
There Is No Difference in Patient Survival after Liver Transplantation between Induction with Rabbit ATG and Basiliximab in Recipients with HCV, However, There Appears To Be Less Severe Fibrosis with rATG
-
Threatened Kidney Allograft: Use of mTOR- Inhibitor Increases All Cause Mortality
-
Three Genotypically Distinct Strains of Pneumocystis Jirovecii Caused an Outbreak of Pneumocystis Pneumonia in Renal and Liver Transplant Recipients
-
Three-Gene Signature of Tolerance for Clinical Application in Kidney Transplant Recipients
-
Three-Year Safety and Efficacy Outcomes in Kidney Transplant Patients Randomized to Steroid Avoidance or Maintenance Steroids with Early Intensified Dosing of Enteric-Coated Mycophenolate Sodium: The INFINITY Study
-
Thrombin Generation and Platelet Activation in a Xenogenic Lung Perfusion Model Determine Survival of GalTKO.hCD46 Transgenic Lungs
-
Thromboembolic Events Are Increased in Heart and Lung Transplant Recipients Who Received Intra-Operative Recombinant Factor VIIa
-
Thymic Evidence of Clone Deletion in the Mixed Chimerism Mediated Allograft Tolerance
-
Thymoglobulin (rATG) Induction Improves Survival in Heart Transplant Recipients: A Retrospective Single-Center Study
-
Thymoglobulin Is Associated with a Significant Reduction in De Novo Donor-Specific Antibodies and Antibody Mediated Rejection in Moderately Sensitized Renal Transplant Recipients
-
Thymoglobulin Is Safe and Effective as Induction Therapy for Early Steroid Withdrawal in Pediatric Renal Transplantation
-
Thymoglobulin Plus Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplant Recipients Treated with Tacrolimus and Mycophenolate Mofetil: 1-Year Results of a Prospective Clinical Trial
-
Tighter Pretransplant Glycemic Control Is Associated with Reduced Cardiovascular Events after Kidney Transplant in Diabetic Patients at 5 and 10 Year Follow-Up
-
TIM-1 Mucin Domain Is Critical in Breg Development, Induction, and Functional Activity
-
TIM-3 Overexpressing T Lymphocytes Prevent Liver Innate Inflammation Response
-
Time in the Operating Room Independently Predicts Blood Utilization, Charges, and a Cost Efficient Practice
-
Time on Waiting List for Patients with High MELD Does Not Influence Graft or Patient Survival after Liver Transplantation
-
Time to Presentation of Donor Derived Infection
-
Time-Varying Relationship between Aboriginal Racial Origin and Transplant Outcomes in Australia, The
-
TIMP-1 Deficiency Promotes p53 Pathway and Impairs Hepatocyte Proliferation in Liver Ischemia Reperfusion Injury
-
Tissue Proteomics Reveals Protein Differences Associated with Allograft Cellular Rejection
-
TLR2 Signaling in Epithelial Cells Initiates Sterile Tissue Inflammation through Recruitment of NK Cells in Renal Ischemia Reperfusion Injury
-
TNF-alpha -238 G-Allele Predisposes to Severe Bacterial Infection in Patients with End-Stage Liver Disease Enlisted for Liver Transplantation, The
-
To Pay or Not To Pay for a Kidney – What Do Patients Think?
-
TOL101 Signaling Pathways, a Novel CD3 Independent T Cell Inactivation & Treg Induction Cascade
-
Tolerance Induction by αLFA1 Monotherapy Reveals Organ Specific CD8-Dependent Immune Mechanisms
-
Tolerance Induction Changes Lymph Node Structure and Function
-
Tolerance of ACE-Inhibitor/ARB Use Post Renal Transplant
-
Tolerance Related Gene Expression in Urine from Kidney Transplant Recipients
-
Tolerance Requires Unique Remodeling of Lymph Node Structure and Stromal Fibers
-
Tolerogenic Effect of Maternal Microchimerism Is Linked to Semi-Direct Pathway, The
-
Toll Like Receptor Signaling Pathway Activated and Inflammation Amplified in Naked Caspase-3 siRNA Preserved Auto-Transplant Porcine Kidneys
-
Toll-Like Receptor 4 Blockade Enhances Islet Engraftment and Induces Indefinite Islet Allograft Survival
-
Total Face and Multi-Organ Procurement from a Brain-Dead Donor: Institutional Experience and Proposed Algorithm
-
Total Plasma Exchange Does Not Improve Allograft Outcome in Deceased Donor Liver Transplant When Performed for Allograft Dysfunction and Positive Cross-Match
-
Totally Laparoscopic Living Liver Donor Procedurement Including Two Full Left Lobes
-
Transgenic Expression of Human Thrombomodulin in Donor Pigs Reduces the Incidence of Coagulopathies in a Pig to Baboon Cardiac Xenotransplantation Model
-
Transitions of Care To Reduce Early Readmissions Following Kidney Transplantation
-
Transmission of Coccidioidomycosis through Organ Transplantation
-
Transplant Certification and Quality Assessment: The Effect of Center Data Input Quality
-
Transplant Dermatology Is an Essential Part of Transplant Care: Report of First Year Experience
-
Transplant Dermatology Referrals Result in Unexpected Non-Malignant Diagnoses
-
Transplant Glomerulopathy – An Analysis of 96 Cases To Determine the Risk Factors of Allograft Failure
-
Transplant Renal Arterial Inflow Stenosis Defined by Contrast Enhanced MR Angiography and MR Imaging in Early Period after Renal Transplantation: Predisposing Factors and Clinical Outcomes
-
Transplantation of CDC High Risk Kidneys: A Low Risk Option for a High Risk Problem
-
Transplantation Outcomes in Treating Primary Hyperoxaluria (PH) in Pittsburgh. Is the Liver Really That Important?
-
Transplantation Tolerance That Depends on Regulatory T Cells Induced by TGF-beta-Producing Regulatory B Cells
-
Transplantation Tourism: High Risk for the Recipients
-
Treatment of Chronic Antibody-Mediated Rejection after Kidney Transplantation: Does Rituximab and Intravenous Globulins Improve Graft Survival?
-
Treatment of Cryptococcosis in Solid-OrganTransplant Recipients: Relapse Is Rare after Discontinuation of Therapy
-
Treatment of Late Onset De Novo Donor Specific Antibody (DSA)-Mediated Pediatric Kidney Transplant Rejection with Bortezomib
-
Treatment of Renal Transplant Patients with Autologous Bone Marrow Derived Mesenchymal Stromal Cells Downregulates the Donor Specific Mixed Lymphocyte Reaction
-
Treatment Option in Diabetic End Stage Renal Disease Patients with Potential Living Kidney Donor: PAK vs. SPLK
-
Treg Express a Unique Pattern of Trafficking Molecules and Differentially Rely on LFA-1 for Migration Compared to Effector T Cells
-
Treg Require Th1 and Th2 Transcription Factors To Prolong Islet Allograft Survival
-
Trends and Utilization of Intestinal Graft Types in Infants and Children ≤ 15 kg
-
Trends in Kidney Transplant Outcomes in Older Adults
-
Trends in Transplant Patient Safety Situation Reporting
-
Trends in Usage and Outcomes for Expanded Criteria Donor Kidney Transplantation
-
Triple Non-Steroidal Maintenance Therapy in a Cohort of Kidney Transplanted Children
-
True MELD Score Is Associated with HCC Patient Outcomes after Liver Transplant
-
Tuberculosis in Kidney Transplant – 10 Years Experience
-
Tumor Necrosis Factor Receptor Type 2 Expression on Regulatory T Cells Predicts Acute Kidney Injury after Kidney Transplantation
-
Tuning the OPTN's KPD Optimization Algorithm To Incentivize Centers To Enter Their "Easy-to-Match" Pairs
-
Twice Daily Telaprevir in Combination with Peginterferon Alfa-2a/Ribavirin in HCV Genotype 1 Liver Transplant Recipients: Interim Pharmacokinetics of the REFRESH Study
-
Twice Daily Telaprevir in Combination with Peginterferon Alfa-2a/Ribavirin in HCV Genotype 1 Liver Transplant Recipients: Interim Safety/Efficacy of the REFRESH Study
2013 American Transplant Congress
May 18-22, 2013 in Seattle, Washington